{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:42:56Z","timestamp":1791855776136,"version":"4.3.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11851-6","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:52:13Z","timestamp":1777099933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mitochondrial dysfunction\u2013driven inflammation and \u03b2-Cell apoptosis in type 2 diabetes mellitus: mechanistic insights and therapeutic implications"],"prefix":"10.1007","volume":"53","author":[{"given":"Satyam","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3102-0069","authenticated-orcid":false,"given":"Sourabh","family":"Kosey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"11851_CR1","unstructured":"Diabetes (2025) accessed September 4, n.d. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes"},{"key":"11851_CR2","unstructured":"Diabetes atlas IDF (2025) accessed September 4,. Diabetes Atlas n.d. https:\/\/diabetesatlas.org\/"},{"key":"11851_CR3","doi-asserted-by":"publisher","first-page":"1401531","DOI":"10.3389\/fendo.2024.1401531","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Miao Y, Feng Q, Zhu W, Chen Y, Kang Q et al (2024) Mitochondrial dysfunction and onset of type 2 diabetes along with its complications: a multi-omics Mendelian randomization and colocalization study. Front Endocrinol 15:1401531. https:\/\/doi.org\/10.3389\/fendo.2024.1401531","journal-title":"Front Endocrinol"},{"key":"11851_CR4","doi-asserted-by":"publisher","first-page":"976465","DOI":"10.3389\/fendo.2022.976465","volume":"13","author":"S You","year":"2022","unstructured":"You S, Zheng J, Chen Y, Huang H (2022) Research progress on the mechanism of beta-cell apoptosis in type 2 diabetes mellitus. Front Endocrinol 13:976465. https:\/\/doi.org\/10.3389\/fendo.2022.976465","journal-title":"Front Endocrinol"},{"key":"11851_CR5","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-18-0091","author":"ML Yee","year":"2018","unstructured":"Yee ML, Wong R, Datta M, Fazio TN, Mohammad Ebrahim M, Mcnamara EC et al (2018) Mitochondrial disease: an uncommon but important cause of diabetes mellitus. Endocrinol Diabetes Metab Case Rep. https:\/\/doi.org\/10.1530\/EDM-18-0091","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"11851_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/pathophysiology32010009","volume":"32","author":"FN Iheagwam","year":"2025","unstructured":"Iheagwam FN, Joseph AJ, Adedoyin ED, Iheagwam OT, Ejoh SA (2025) Mitochondrial Dysfunction in Diabetes: Shedding Light on a Widespread Oversight. Pathophysiology 32:9. https:\/\/doi.org\/10.3390\/pathophysiology32010009","journal-title":"Pathophysiology"},{"key":"11851_CR7","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3390\/antiox12061163","volume":"12","author":"T Yu","year":"2023","unstructured":"Yu T, Wang L, Zhang L, Deuster PA (2023) Mitochondrial Fission as a Therapeutic Target for Metabolic Diseases: Insights into Antioxidant Strategies. Antioxidants 12:1163. https:\/\/doi.org\/10.3390\/antiox12061163","journal-title":"Antioxidants"},{"key":"11851_CR8","doi-asserted-by":"publisher","first-page":"13782","DOI":"10.3390\/ijms241813782","volume":"24","author":"UD Kabra","year":"2023","unstructured":"Kabra UD, Jastroch M (2023) Mitochondrial Dynamics and Insulin Secretion. Int J Mol Sci 24:13782. https:\/\/doi.org\/10.3390\/ijms241813782","journal-title":"Int J Mol Sci"},{"key":"11851_CR9","doi-asserted-by":"publisher","first-page":"116954","DOI":"10.1016\/j.ecoenv.2024.116954","volume":"284","author":"C Chen","year":"2024","unstructured":"Chen C, Chen Y, Zhai H, Xiao Y, Xu J, Gu Y et al (2024) Cadmium exposure induces skeletal muscle insulin resistance through the reactive oxygen species-mediated PINK1\/Parkin pathway. Ecotoxicol Environ Saf 284:116954. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.116954","journal-title":"Ecotoxicol Environ Saf"},{"key":"11851_CR10","doi-asserted-by":"publisher","first-page":"e141138","DOI":"10.1172\/jci.insight.141138","volume":"5","author":"V Sidarala","year":"2020","unstructured":"Sidarala V, Pearson GL, Parekh VS, Thompson B, Christen L, Gingerich MA et al (2020) Mitophagy protects \u03b2 cells from inflammatory damage in diabetes. JCI Insight 5:e141138. https:\/\/doi.org\/10.1172\/jci.insight.141138","journal-title":"JCI Insight"},{"key":"11851_CR11","doi-asserted-by":"publisher","first-page":"e14138","DOI":"10.1111\/eci.14138","volume":"54","author":"A Zimmermann","year":"2024","unstructured":"Zimmermann A, Madeo F, Diwan A, Sadoshima J, Sedej S, Kroemer G et al (2024) Metabolic control of mitophagy. Eur J Clin Invest 54:e14138. https:\/\/doi.org\/10.1111\/eci.14138","journal-title":"Eur J Clin Invest"},{"key":"11851_CR12","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/ijms25031504","volume":"25","author":"R Veluthakal","year":"2024","unstructured":"Veluthakal R, Esparza D, Hoolachan JM, Balakrishnan R, Ahn M, Oh E et al (2024) Mitochondrial Dysfunction, Oxidative Stress, and Inter-Organ Miscommunications in T2D Progression. Int J Mol Sci 25:1504. https:\/\/doi.org\/10.3390\/ijms25031504","journal-title":"Int J Mol Sci"},{"key":"11851_CR13","doi-asserted-by":"publisher","first-page":"110024","DOI":"10.1016\/j.exer.2024.110024","volume":"247","author":"AG D\u2019Amico","year":"2024","unstructured":"D\u2019Amico AG, Maugeri G, Magr\u00ec B, Bucolo C, D\u2019Agata V (2024) Targeting the PINK1\/Parkin pathway: A new perspective in the prevention and therapy of diabetic retinopathy. Exp Eye Res 247:110024. https:\/\/doi.org\/10.1016\/j.exer.2024.110024","journal-title":"Exp Eye Res"},{"key":"11851_CR14","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1242\/jcs.146365","volume":"129","author":"G Napolitano","year":"2016","unstructured":"Napolitano G, Ballabio A (2016) TFEB at a glance. J Cell Sci 129:2475\u20132481. https:\/\/doi.org\/10.1242\/jcs.146365","journal-title":"J Cell Sci"},{"key":"11851_CR15","doi-asserted-by":"publisher","first-page":"1354199","DOI":"10.3389\/fmolb.2024.1354199","volume":"11","author":"AM Rivera Nieves","year":"2024","unstructured":"Rivera Nieves AM, Wauford BM, Fu A (2024) Mitochondrial bioenergetics, metabolism, and beyond in pancreatic \u03b2-cells and diabetes. Front Mol Biosci 11:1354199. https:\/\/doi.org\/10.3389\/fmolb.2024.1354199","journal-title":"Front Mol Biosci"},{"key":"11851_CR16","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/cells10020352","volume":"10","author":"LJ McMeekin","year":"2021","unstructured":"McMeekin LJ, Fox SN, Boas SM, Cowell RM (2021) Dysregulation of PGC-1\u03b1-Dependent Transcriptional Programs in Neurological and Developmental Disorders: Therapeutic Challenges and Opportunities. Cells 10:352. https:\/\/doi.org\/10.3390\/cells10020352","journal-title":"Cells"},{"key":"11851_CR17","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB et al (2020) Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci 21:6275. https:\/\/doi.org\/10.3390\/ijms21176275","journal-title":"Int J Mol Sci"},{"key":"11851_CR18","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2019.4188","author":"R Zhao","year":"2019","unstructured":"Zhao R, Jiang S, Zhang L, Yu Z (2019) Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2019.4188","journal-title":"Int J Mol Med"},{"key":"11851_CR19","doi-asserted-by":"publisher","first-page":"1112363","DOI":"10.3389\/fendo.2023.1112363","volume":"14","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Huang Q, Zhao D, Lian F, Li X, Qi W (2023) The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications. Front Endocrinol 14:1112363. https:\/\/doi.org\/10.3389\/fendo.2023.1112363","journal-title":"Front Endocrinol"},{"key":"11851_CR20","doi-asserted-by":"publisher","first-page":"117931","DOI":"10.1016\/j.jep.2024.117931","volume":"327","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zhang S, Zhang Y, Wang H, Chen Y, Lu H (2024) Activation of NRF2 by epiberberine improves oxidative stress and insulin resistance in T2DM mice and IR-HepG2 cells in an AMPK dependent manner. J Ethnopharmacol 327:117931. https:\/\/doi.org\/10.1016\/j.jep.2024.117931","journal-title":"J Ethnopharmacol"},{"key":"11851_CR21","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.4239\/wjd.v15.i8.1753","volume":"15","author":"Y Ding","year":"2024","unstructured":"Ding Y, Yu X-J, Guo Q-X, Leng J-H (2024) Functional analysis of the novel mitochondrial tRNATrp and tRNASer(AGY) variants associated with type 2 diabetes mellitus. World J Diabetes 15:1753\u20131763. https:\/\/doi.org\/10.4239\/wjd.v15.i8.1753","journal-title":"World J Diabetes"},{"key":"11851_CR22","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2147\/DMSO.S363978","volume":"15","author":"Y Ding","year":"2022","unstructured":"Ding Y, Zhang S, Guo Q, Zheng H (2022) Mitochondrial diabetes is associated with tRNALeu(UUR) A3243G and ND6 T14502C mutations. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 15:1687\u2013701. https:\/\/doi.org\/10.2147\/DMSO.S363978","journal-title":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"},{"key":"11851_CR23","doi-asserted-by":"publisher","first-page":"953631","DOI":"10.3389\/fendo.2022.953631","volume":"13","author":"M Li","year":"2022","unstructured":"Li M, Gong S, Han X, Zhou L, Zhang S, Ren Q et al (2022) Contribution of mitochondrial gene variants in diabetes and diabetic kidney disease. Front Endocrinol 13:953631. https:\/\/doi.org\/10.3389\/fendo.2022.953631","journal-title":"Front Endocrinol"},{"key":"11851_CR24","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.3390\/ijms22136733","volume":"22","author":"SA Dabravolski","year":"2021","unstructured":"Dabravolski SA, Orekhova VA, Baig MS, Bezsonov EE, Starodubova AV, Popkova TV et al (2021) The Role of Mitochondrial Mutations and Chronic Inflammation in Diabetes. Int J Mol Sci 22:6733. https:\/\/doi.org\/10.3390\/ijms22136733","journal-title":"Int J Mol Sci"},{"key":"11851_CR25","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.2337\/db18-0900","volume":"68","author":"E Hall","year":"2019","unstructured":"Hall E, J\u00f6nsson J, Ofori JK, Volkov P, Perfilyev A, Dekker Nitert M et al (2019) Glucolipotoxicity Alters Insulin Secretion via Epigenetic Changes in Human Islets. Diabetes 68:1965\u20131974. https:\/\/doi.org\/10.2337\/db18-0900","journal-title":"Diabetes"},{"key":"11851_CR26","doi-asserted-by":"publisher","first-page":"853822","DOI":"10.3389\/fendo.2022.853822","volume":"13","author":"X-D Yang","year":"2022","unstructured":"Yang X-D, Yang Y-Y (2022) Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications. Front Endocrinol 13:853822. https:\/\/doi.org\/10.3389\/fendo.2022.853822","journal-title":"Front Endocrinol"},{"key":"11851_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2337\/dbi19-0014","volume":"69","author":"M Prentki","year":"2020","unstructured":"Prentki M, Peyot M-L, Masiello P, Madiraju SRM (2020) Nutrient-induced metabolic stress, adaptation, detoxification, and toxicity in the pancreatic \u03b2-cell. Diabetes 69:279\u2013290. https:\/\/doi.org\/10.2337\/dbi19-0014","journal-title":"Diabetes"},{"key":"11851_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.biopha.2018.07.157","volume":"107","author":"B Giri","year":"2018","unstructured":"Giri B, Dey S, Das T, Sarkar M, Banerjee J, Dash SK (2018) Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomed Pharmacother 107:306\u2013328. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.157","journal-title":"Biomed Pharmacother"},{"key":"11851_CR29","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.2337\/db19-0813","volume":"69","author":"J Vogel","year":"2020","unstructured":"Vogel J, Yin J, Su L, Wang SX, Zessis R, Fowler S et al (2020) A Phenotypic Screen Identifies Calcium Overload as a Key Mechanism of \u03b2-Cell Glucolipotoxicity. Diabetes 69:1032\u20131041. https:\/\/doi.org\/10.2337\/db19-0813","journal-title":"Diabetes"},{"key":"11851_CR30","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","volume":"178","author":"CA Jurgens","year":"2011","unstructured":"Jurgens CA, Toukatly MN, Fligner CL, Udayasankar J, Subramanian SL, Zraika S et al (2011) \u03b2-Cell Loss and \u03b2-Cell Apoptosis in Human Type 2 Diabetes Are Related to Islet Amyloid Deposition. Am J Pathol 178:2632\u20132640. https:\/\/doi.org\/10.1016\/j.ajpath.2011.02.036","journal-title":"Am J Pathol"},{"key":"11851_CR31","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1007\/s00125-016-4045-x","volume":"59","author":"DT Meier","year":"2016","unstructured":"Meier DT, Entrup L, Templin AT, Hogan MF, Mellati M, Zraika S et al (2016) The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets. Diabetologia 59:2166\u20132171. https:\/\/doi.org\/10.1007\/s00125-016-4045-x","journal-title":"Diabetologia"},{"key":"11851_CR32","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1172\/JCI69866","volume":"124","author":"N Shigihara","year":"2014","unstructured":"Shigihara N, Fukunaka A, Hara A, Komiya K, Honda A, Uchida T et al (2014) Human IAPP\u2013induced pancreatic \u03b2 cell toxicity and its regulation by autophagy. J Clin Invest 124:3634\u20133644. https:\/\/doi.org\/10.1172\/JCI69866","journal-title":"J Clin Invest"},{"key":"11851_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0925-4439(01)00078-3","volume":"1537","author":"ETAS Jaikaran","year":"2001","unstructured":"Jaikaran ETAS, Clark A (2001) Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim Biophys Acta BBA -. Mol Basis Dis 1537:179\u2013203. https:\/\/doi.org\/10.1016\/S0925-4439(01)00078-3","journal-title":"Mol Basis Dis"},{"key":"11851_CR34","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1038\/srep04267","volume":"4","author":"Y Bram","year":"2014","unstructured":"Bram Y, Frydman-Marom A, Yanai I, Gilead S, Shaltiel-Karyo R, Amdursky N et al (2014) Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies. Sci Rep 4:4267. https:\/\/doi.org\/10.1038\/srep04267","journal-title":"Sci Rep"},{"key":"11851_CR35","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.3390\/ijms22105303","volume":"22","author":"S Costes","year":"2021","unstructured":"Costes S, Bertrand G, Ravier MA (2021) Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies. Int J Mol Sci 22:5303. https:\/\/doi.org\/10.3390\/ijms22105303","journal-title":"Int J Mol Sci"},{"key":"11851_CR36","doi-asserted-by":"publisher","first-page":"7483","DOI":"10.1038\/s41598-022-11100-3","volume":"12","author":"M Nouri Barkestani","year":"2022","unstructured":"Nouri Barkestani M, Naserian S, Khoddam F, Shamdani S, Bambai B (2022) Optimization of IL-1RA structure to achieve a smaller protein with a higher affinity to its receptor. Sci Rep 12:7483. https:\/\/doi.org\/10.1038\/s41598-022-11100-3","journal-title":"Sci Rep"},{"key":"11851_CR37","doi-asserted-by":"publisher","first-page":"107776","DOI":"10.1016\/j.phrs.2025.107776","volume":"216","author":"J Chen","year":"2025","unstructured":"Chen J, Fei S, Chan LWC, Gan X, Shao B, Jiang H et al (2025) Inflammatory signaling pathways in pancreatic \u03b2-cell: New insights into type 2 diabetes pathogenesis. Pharmacol Res 216:107776. https:\/\/doi.org\/10.1016\/j.phrs.2025.107776","journal-title":"Pharmacol Res"},{"key":"11851_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.69860\/nobel.9786053359104.12","volume-title":"Curr. Multidiscip. Approach Diabetes Mellit. Occur. Mech","author":"D Dasdelen","year":"2023","unstructured":"Dasdelen D (2023) Apoptosis Induced by Diabetes. In: Alp H, Ragbetli MC, Koksoy H (eds) Curr. Multidiscip. Approach Diabetes Mellit. Occur. Mech, 1st edn. Nobel Tip Kitabevleri, Istanbul, pp 133\u2013139. https:\/\/doi.org\/10.69860\/nobel.9786053359104.12.","edition":"1"},{"key":"11851_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3892\/mmr.2024.13317","volume":"30","author":"L Flores\u2013L\u00f3pez","year":"2024","unstructured":"Flores\u2013L\u00f3pez L, Enr\u00edquez\u2013Flores S, De La Mora\u2013De I, Garc\u00eda\u2013Torres I, L\u00f3pez\u2013Vel\u00e1zquez G, Viedma\u2013Rodr\u00edguez R et al (2024) Pancreatic \u03b2\u2013cell apoptosis in type 2 diabetes is related to post\u2013translational modifications of p53 (Review). Mol Med Rep 30:193. https:\/\/doi.org\/10.3892\/mmr.2024.13317","journal-title":"Mol Med Rep"},{"key":"11851_CR40","doi-asserted-by":"publisher","first-page":"16809","DOI":"10.1038\/s41598-024-67867-0","volume":"14","author":"X Jia","year":"2024","unstructured":"Jia X, Mao D, Guo J, Ke J, Zhu Y, Zhao X et al (2024) Epigallocatechin gallate attenuated high glucose-induced pancreatic beta cell dysfunction by modulating DRP1-mediated mitochondrial apoptosis pathways. Sci Rep 14:16809. https:\/\/doi.org\/10.1038\/s41598-024-67867-0","journal-title":"Sci Rep"},{"key":"11851_CR41","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.biocel.2006.09.007","volume":"39","author":"SC Lee","year":"2007","unstructured":"Lee SC, Pervaiz S (2007) Apoptosis in the pathophysiology of diabetes mellitus. Int J Biochem Cell Biol 39:497\u2013504. https:\/\/doi.org\/10.1016\/j.biocel.2006.09.007","journal-title":"Int J Biochem Cell Biol"},{"key":"11851_CR42","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41392-023-01570-w","volume":"8","author":"X Chen","year":"2023","unstructured":"Chen X, Shi C, He M, Xiong S, Xia X (2023) Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. Signal Transduct Target Ther 8:352. https:\/\/doi.org\/10.1038\/s41392-023-01570-w","journal-title":"Signal Transduct Target Ther"},{"key":"11851_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41420-022-00830-y","volume":"8","author":"C Hagenlocher","year":"2022","unstructured":"Hagenlocher C, Siebert R, Taschke B, Wieske S, Hausser A, Rehm M (2022) ER stress-induced cell death proceeds independently of the TRAIL-R2 signaling axis in pancreatic \u03b2 cells. Cell Death Discov 8:34. https:\/\/doi.org\/10.1038\/s41420-022-00830-y","journal-title":"Cell Death Discov"},{"key":"11851_CR44","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3390\/ijms18112313","volume":"18","author":"J \u0160r\u00e1mek","year":"2017","unstructured":"\u0160r\u00e1mek J, N\u011bmcov\u00e1-F\u00fcrstov\u00e1 V, Pavl\u00edkov\u00e1 N, Kov\u00e1\u0159 J (2017) Effect of Saturated Stearic Acid on MAP Kinase and ER Stress Signaling Pathways during Apoptosis Induction in Human Pancreatic \u03b2-Cells Is Inhibited by Unsaturated Oleic Acid. Int J Mol Sci 18:2313. https:\/\/doi.org\/10.3390\/ijms18112313","journal-title":"Int J Mol Sci"},{"key":"11851_CR45","doi-asserted-by":"publisher","first-page":"115691","DOI":"10.1016\/j.celrep.2025.115691","volume":"44","author":"N Sue","year":"2025","unstructured":"Sue N, Thai LM, Boslem E, Chu KY, Yan C, Mackin L et al (2025) ER stress disrupts insulin release in murine models of type 2 diabetes by impairing retromer action and constitutive secretion. Cell Rep 44:115691. https:\/\/doi.org\/10.1016\/j.celrep.2025.115691","journal-title":"Cell Rep"},{"key":"11851_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/biom11020173","volume":"11","author":"V Kumar","year":"2021","unstructured":"Kumar V, Maity S (2021) ER Stress-Sensor Proteins and ER-Mitochondrial Crosstalk\u2014Signaling Beyond (ER) Stress Response. Biomolecules 11:173. https:\/\/doi.org\/10.3390\/biom11020173","journal-title":"Biomolecules"},{"key":"11851_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tcb.2024.08.007","volume":"35","author":"A Larra\u00f1aga-SanMiguel","year":"2025","unstructured":"Larra\u00f1aga-SanMiguel A, Bengoa-Vergniory N, Flores-Romero H (2025) Crosstalk between mitochondria\u2013ER contact sites and the apoptotic machinery as a novel health meter. Trends Cell Biol 35:33\u201345. https:\/\/doi.org\/10.1016\/j.tcb.2024.08.007","journal-title":"Trends Cell Biol"},{"key":"11851_CR48","doi-asserted-by":"publisher","first-page":"e0117567","DOI":"10.1371\/journal.pone.0117567","volume":"10","author":"J Shi","year":"2015","unstructured":"Shi J, Jiang Q, Ding X, Xu W, Wang DW, Chen M (2015) The ER Stress-Mediated Mitochondrial Apoptotic Pathway and MAPKs Modulate Tachypacing-Induced Apoptosis in HL-1 Atrial Myocytes. PLoS ONE 10:e0117567. https:\/\/doi.org\/10.1371\/journal.pone.0117567","journal-title":"PLoS ONE"},{"key":"11851_CR49","doi-asserted-by":"publisher","first-page":"115711","DOI":"10.1016\/j.ecoenv.2023.115711","volume":"268","author":"H Zhang","year":"2023","unstructured":"Zhang H, Ran M, Jiang L, Sun X, Qiu T, Li J et al (2023) Mitochondrial dysfunction and endoplasmic reticulum stress induced by activation of PPAR\u03b1 leaded testicular to apoptosis in SD rats explored to di-(2-ethylhexyl) phthalate (DEHP). Ecotoxicol Environ Saf 268:115711. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.115711","journal-title":"Ecotoxicol Environ Saf"},{"key":"11851_CR50","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.3390\/ijms21186948","volume":"21","author":"AJ Genders","year":"2020","unstructured":"Genders AJ, Holloway GP, Bishop DJ (2020) Are Alterations in Skeletal Muscle Mitochondria a Cause or Consequence of Insulin Resistance? Int J Mol Sci 21:6948. https:\/\/doi.org\/10.3390\/ijms21186948","journal-title":"Int J Mol Sci"},{"key":"11851_CR51","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fphys.2019.00532","volume":"10","author":"D Sergi","year":"2019","unstructured":"Sergi D, Naumovski N, Heilbronn LK, Abeywardena M, O\u2019Callaghan N, Lionetti L et al (2019) Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet. Front Physiol 10:532. https:\/\/doi.org\/10.3389\/fphys.2019.00532","journal-title":"Front Physiol"},{"key":"11851_CR52","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s11916-024-01243-5","volume":"28","author":"N Strand","year":"2024","unstructured":"Strand N, Anderson MA, Attanti S, Gill B, Wie C, Dawodu A et al (2024) Diabetic Neuropathy: Pathophysiology Review. Curr Pain Headache Rep 28:481\u2013487. https:\/\/doi.org\/10.1007\/s11916-024-01243-5","journal-title":"Curr Pain Headache Rep"},{"key":"11851_CR53","doi-asserted-by":"publisher","first-page":"109793","DOI":"10.1016\/j.intimp.2023.109793","volume":"116","author":"I Khan","year":"2023","unstructured":"Khan I, Preeti K, Kumar R, Kumar Khatri D, Bala Singh S (2023) Piceatannol promotes neuroprotection by inducing mitophagy and mitobiogenesis in the experimental diabetic peripheral neuropathy and hyperglycemia-induced neurotoxicity. Int Immunopharmacol 116:109793. https:\/\/doi.org\/10.1016\/j.intimp.2023.109793","journal-title":"Int Immunopharmacol"},{"key":"11851_CR54","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1016\/j.ekir.2024.09.019","volume":"9","author":"P Narongkiatikhun","year":"2024","unstructured":"Narongkiatikhun P, Choi YJ, Hampson H, Gotzamanis J, Zhang G, Van Raalte DH et al (2024) Unraveling Diabetic Kidney Disease: The Roles of Mitochondrial Dysfunction and Immunometabolism. Kidney Int Rep 9:3386\u20133402. https:\/\/doi.org\/10.1016\/j.ekir.2024.09.019","journal-title":"Kidney Int Rep"},{"key":"11851_CR55","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/biom14060733","volume":"14","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu J, Shi Q, Guo B, Jia H, Yang Y et al (2024) Roles of Mitochondrial Dysfunction in Diabetic Kidney Disease: New Perspectives from Mechanism to Therapy. Biomolecules 14:733. https:\/\/doi.org\/10.3390\/biom14060733","journal-title":"Biomolecules"},{"key":"11851_CR56","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5152\/tjg.2016.16106","volume":"27","author":"E Koroglu","year":"2016","unstructured":"Koroglu E, Canbakan B, Atay K, Hatemi I, Tuncer M, Dobrucali A et al (2016) Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease. Turk J Gastroenterol 27:361\u2013366. https:\/\/doi.org\/10.5152\/tjg.2016.16106","journal-title":"Turk J Gastroenterol"},{"key":"11851_CR57","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.3390\/ijms23137280","volume":"23","author":"R Ramanathan","year":"2022","unstructured":"Ramanathan R, Ali AH, Ibdah JA (2022) Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease. Int J Mol Sci 23:7280. https:\/\/doi.org\/10.3390\/ijms23137280","journal-title":"Int J Mol Sci"},{"key":"11851_CR58","doi-asserted-by":"publisher","first-page":"118585","DOI":"10.1016\/j.ecoenv.2025.118585","volume":"302","author":"Y Tang","year":"2025","unstructured":"Tang Y, Suo Y, Sun Z, Wu X, Xing Q, Bai Y (2025) Microplastics induce insulin resistance by causing mitochondrial dysfunction associated with mROS in skeletal muscle in vitro. Ecotoxicol Environ Saf 302:118585. https:\/\/doi.org\/10.1016\/j.ecoenv.2025.118585","journal-title":"Ecotoxicol Environ Saf"},{"key":"11851_CR59","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.3390\/ijms26073195","volume":"26","author":"N Espinoza","year":"2025","unstructured":"Espinoza N, Papadopoulos V (2025) Role of Mitochondrial Dysfunction in Neuropathy. Int J Mol Sci 26:3195. https:\/\/doi.org\/10.3390\/ijms26073195","journal-title":"Int J Mol Sci"},{"key":"11851_CR60","doi-asserted-by":"publisher","first-page":"101972","DOI":"10.1016\/j.mito.2024.101972","volume":"79","author":"K Sriwastawa","year":"2024","unstructured":"Sriwastawa K, Kumar A (2024) Mitochondrial dysfunction in diabetic neuropathy: Impaired mitophagy triggers NLRP3 inflammasome. Mitochondrion 79:101972. https:\/\/doi.org\/10.1016\/j.mito.2024.101972","journal-title":"Mitochondrion"},{"key":"11851_CR61","doi-asserted-by":"publisher","first-page":"1429420","DOI":"10.3389\/fendo.2024.1429420","volume":"15","author":"D Zhao","year":"2024","unstructured":"Zhao D, Zhong R, Wang X, Yan Z (2024) Mitochondrial dysfunction in diabetic nephropathy: insights and therapeutic avenues from traditional Chinese medicine. Front Endocrinol 15:1429420. https:\/\/doi.org\/10.3389\/fendo.2024.1429420","journal-title":"Front Endocrinol"},{"key":"11851_CR62","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41419-024-06833-0","volume":"15","author":"X Fan","year":"2024","unstructured":"Fan X, Yang M, Lang Y, Lu S, Kong Z, Gao Y et al (2024) Mitochondrial metabolic reprogramming in diabetic kidney disease. Cell Death Dis 15:442. https:\/\/doi.org\/10.1038\/s41419-024-06833-0","journal-title":"Cell Death Dis"},{"key":"11851_CR63","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","volume":"52","author":"RS Rector","year":"2010","unstructured":"Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ et al (2010) Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 52:727\u2013736. https:\/\/doi.org\/10.1016\/j.jhep.2009.11.030","journal-title":"J Hepatol"},{"key":"11851_CR64","doi-asserted-by":"publisher","first-page":"1569866","DOI":"10.3389\/fendo.2025.1569866","volume":"16","author":"Y Kang","year":"2025","unstructured":"Kang Y, Zhao J, Liu J (2025) Zinc sulfate improves insulin resistance, oxidative stress and apoptosis in liver tissues of PCOS rats through the NF-\u03baB pathway. Front Endocrinol 16:1569866. https:\/\/doi.org\/10.3389\/fendo.2025.1569866","journal-title":"Front Endocrinol"},{"key":"11851_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8837893","volume":"2020","author":"Q Jiang","year":"2020","unstructured":"Jiang Q, Yin J, Chen J, Ma X, Wu M, Liu G et al (2020) Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment. Oxid Med Cell Longev 2020:1\u201318. https:\/\/doi.org\/10.1155\/2020\/8837893","journal-title":"Oxid Med Cell Longev"},{"key":"11851_CR66","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.3390\/antiox10111824","volume":"10","author":"G Napolitano","year":"2021","unstructured":"Napolitano G, Fasciolo G, Venditti P (2021) Mitochondrial Management of Reactive Oxygen Species. Antioxidants 10:1824. https:\/\/doi.org\/10.3390\/antiox10111824","journal-title":"Antioxidants"},{"key":"11851_CR67","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.redox.2016.12.022","volume":"11","author":"L Xiao","year":"2017","unstructured":"Xiao L, Xu X, Zhang F, Wang M, Xu Y, Tang D et al (2017) The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2\/PINK1. Redox Biol 11:297\u2013311. https:\/\/doi.org\/10.1016\/j.redox.2016.12.022","journal-title":"Redox Biol"},{"key":"11851_CR68","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41419-024-07216-1","volume":"15","author":"S-K Jang","year":"2024","unstructured":"Jang S-K, Ahn SH, Kim G, Kim S, Hong J, Park KS et al (2024) Inhibition of VDAC1 oligomerization blocks cysteine deprivation-induced ferroptosis via mitochondrial ROS suppression. Cell Death Dis 15:811. https:\/\/doi.org\/10.1038\/s41419-024-07216-1","journal-title":"Cell Death Dis"},{"key":"11851_CR69","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6408278","volume":"2017","author":"IA Demyanenko","year":"2017","unstructured":"Demyanenko IA, Zakharova VV, Ilyinskaya OP, Vasilieva TV, Fedorov AV, Manskikh VN et al (2017) Mitochondria-targeted antioxidant SkQ1 improves dermal wound healing in genetically diabetic mice. Oxid Med Cell Longev 2017:6408278. https:\/\/doi.org\/10.1155\/2017\/6408278","journal-title":"Oxid Med Cell Longev"},{"key":"11851_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12030658","volume":"12","author":"K-A Cojocaru","year":"2023","unstructured":"Cojocaru K-A, Luchian I, Goriuc A, Antoci L-M, Ciobanu C-G, Popescu R et al (2023) Mitochondrial dysfunction, oxidative stress, and therapeutic strategies in diabetes, obesity, and cardiovascular disease. Antioxidants 12:658. https:\/\/doi.org\/10.3390\/antiox12030658","journal-title":"Antioxidants"},{"key":"11851_CR71","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2025.05.431","volume":"237","author":"T Duan","year":"2025","unstructured":"Duan T, Sun L, Xi Y, Li C, Zhao Q, Xu L et al (2025) Mito-tempo ameliorates tubular injury of diabetic nephropathy via inhibiting mt-dsRNA release and PKR\/eIF2\u03b1 pathway activation. Free Radic Biol Med 237:147\u201359. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.05.431","journal-title":"Free Radic Biol Med"},{"key":"11851_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2024.100577","volume":"53","author":"S Aydin","year":"2025","unstructured":"Aydin S, Tekinalp SG, Tuzcu B, Cam F, Sevik MO, Tatar E et al (2025) The role of AMP-activated protein kinase activators on energy balance and cellular metabolism in type 2 diabetes mellitus. Obesity Medicine 53:100577. https:\/\/doi.org\/10.1016\/j.obmed.2024.100577","journal-title":"Obesity Medicine"},{"key":"11851_CR73","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.gendis.2015.12.002","volume":"3","author":"B Zhao","year":"2016","unstructured":"Zhao B, Qiang L, Joseph J, Kalyanaraman B, Viollet B, He Y-Y (2016) Mitochondrial dysfunction activates the AMPK signaling and autophagy to promote cell survival. Genes & Diseases 3:82\u20137. https:\/\/doi.org\/10.1016\/j.gendis.2015.12.002","journal-title":"Genes & Diseases"},{"key":"11851_CR74","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1172\/JCI66218","volume":"123","author":"LL Dugan","year":"2013","unstructured":"Dugan LL, You Y-H, Ali SS, Diamond-Stanic M, Miyamoto S, DeCleves A-E et al (2013) AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J Clin Invest 123:4888\u201399. https:\/\/doi.org\/10.1172\/JCI66218","journal-title":"J Clin Invest"},{"key":"11851_CR75","unstructured":"L W, Y Q, W N, Y L, W L, Y P, et al. [Linagliptin improves diabetic kidney disease in rats by promoting mitochondrial biogenesis through the AMPK\/PGC-1 \u03b1\/TFAM pathway]. PubMed (2023)"},{"key":"11851_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112563","volume":"146","author":"M Entezari","year":"2022","unstructured":"Entezari M, Hashemi D, Taheriazam A, Zabolian A, Mohammadi S, Fakhri F et al (2022) AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: a pre-clinical and clinical investigation. Biomed Pharmacother 146:112563. https:\/\/doi.org\/10.1016\/j.biopha.2021.112563","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"11851_CR77","doi-asserted-by":"publisher","first-page":"530","DOI":"10.5455\/jabet.2024.d46","volume":"7","author":"T Amin","year":"2024","unstructured":"Amin T, Jerin N, Hossain A, Siddiqi S, Islam S, Selim S (2024) Tracing mitochondrial dysfunction pathways in type 2 diabetes: the promise of mitochondria-targeted therapeutics. J Adv Biotechnol Exp Ther 7:530. https:\/\/doi.org\/10.5455\/jabet.2024.d46","journal-title":"J Adv Biotechnol Exp Ther"},{"key":"11851_CR78","doi-asserted-by":"publisher","first-page":"101183","DOI":"10.1016\/j.ymgmr.2024.101183","volume":"42","author":"KS PK","year":"2025","unstructured":"PK KS, Jyothi MN, Prashant A (2025) Mitochondrial DNA variants in the pathogenesis and metabolic alterations of diabetes mellitus. Mol Genet Metab Rep 42:101183. https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101183","journal-title":"Mol Genet Metab Rep"},{"key":"11851_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2025.13523","volume":"31","author":"M Liu","year":"2025","unstructured":"Liu M, Qiao H (2025) Role and mechanism of mitochondrial dysfunction\u2013related gene biomarkers in the progression of type 2 diabetes mellitus. Mol Med Rep 31:1\u201321. https:\/\/doi.org\/10.3892\/mmr.2025.13523","journal-title":"Mol Med Rep"},{"key":"11851_CR80","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/pharmaceutics15020572","volume":"15","author":"R Faria","year":"2023","unstructured":"Faria R, Boisgu\u00e9rin P, Sousa \u00c2, Costa D (2023) Delivery Systems for Mitochondrial Gene Therapy: A Review. Pharmaceutics 15:572. https:\/\/doi.org\/10.3390\/pharmaceutics15020572","journal-title":"Pharmaceutics"},{"key":"11851_CR81","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.gendis.2020.03.003","volume":"8","author":"D Yao","year":"2021","unstructured":"Yao D, GangYi Y, QiNan W (2021) Autophagic dysfunction of \u03b2 cell dysfunction in type 2 diabetes, a double-edged sword. Genes Dis 8:438\u2013447. https:\/\/doi.org\/10.1016\/j.gendis.2020.03.003","journal-title":"Genes Dis"},{"key":"11851_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4093\/dmj.2024.0796","volume":"49","author":"IR Park","year":"2025","unstructured":"Park IR, Chung YG, Won KC (2025) Overcoming \u03b2-Cell Dysfunction in Type 2 Diabetes Mellitus: CD36 Inhibition and Antioxidant System. Diabetes Metab J 49:1\u201312. https:\/\/doi.org\/10.4093\/dmj.2024.0796","journal-title":"Diabetes Metab J"},{"key":"11851_CR83","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41419-020-2365-8","volume":"11","author":"J-H Lee","year":"2020","unstructured":"Lee J-H, Mellado-Gil JM, Bahn YJ, Pathy SM, Zhang YE, Rane SG (2020) Protection from \u03b2-cell apoptosis by inhibition of TGF-\u03b2\/Smad3 signaling. Cell Death Dis 11:184. https:\/\/doi.org\/10.1038\/s41419-020-2365-8","journal-title":"Cell Death Dis"},{"key":"11851_CR84","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1530\/REM-22-0012","volume":"2022","author":"AM De Mara\u00f1\u00f3n","year":"2022","unstructured":"De Mara\u00f1\u00f3n AM, Rovira-Llopis S, Rocha M, V\u00edctor VM (2022) Targeting mitochondria: a great boon to fight type 2 diabetes. Redox Exp Med 2022:R127\u2013R138. https:\/\/doi.org\/10.1530\/REM-22-0012","journal-title":"Redox Exp Med"},{"key":"11851_CR85","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1073\/pnas.1303360110","volume":"110","author":"AS Divakaruni","year":"2013","unstructured":"Divakaruni AS, Wiley SE, Rogers GW, Andreyev AY, Petrosyan S, Loviscach M et al (2013) Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier. Proc Natl Acad Sci 110:5422\u20135427. https:\/\/doi.org\/10.1073\/pnas.1303360110","journal-title":"Proc Natl Acad Sci"},{"key":"11851_CR86","doi-asserted-by":"publisher","first-page":"e61551","DOI":"10.1371\/journal.pone.0061551","volume":"8","author":"JR Colca","year":"2013","unstructured":"Colca JR, McDonald WG, Cavey GS, Cole SL, Holewa DD, Brightwell-Conrad AS et al (2013) Identification of a Mitochondrial Target of Thiazolidinedione Insulin Sensitizers (mTOT)\u2014Relationship to Newly Identified Mitochondrial Pyruvate Carrier Proteins. PLoS ONE 8:e61551. https:\/\/doi.org\/10.1371\/journal.pone.0061551","journal-title":"PLoS ONE"},{"key":"11851_CR87","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4103\/phrev.phrev_41_16","volume":"11","author":"A Kaikini","year":"2017","unstructured":"Kaikini A, Kanchan D, Nerurkar U, Sathaye S (2017) Targeting mitochondrial dysfunction for the treatment of diabetic complications: Pharmacological interventions through natural products. Pharmacogn Rev 11:128. https:\/\/doi.org\/10.4103\/phrev.phrev_41_16","journal-title":"Pharmacogn Rev"},{"key":"11851_CR88","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju AK, Erion DM, Rahimi Y, Zhang X-M, Braddock DT, Albright RA et al (2014) Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510:542\u2013546. https:\/\/doi.org\/10.1038\/nature13270","journal-title":"Nature"},{"key":"11851_CR89","doi-asserted-by":"publisher","first-page":"117414","DOI":"10.1016\/j.lfs.2020.117414","volume":"247","author":"D Wei","year":"2020","unstructured":"Wei D, Liao L, Wang H, Zhang W, Wang T, Xu Z (2020) Canagliflozin ameliorates obesity by improving mitochondrial function and fatty acid oxidation via PPAR\u03b1 in vivo and in vitro. Life Sci 247:117414. https:\/\/doi.org\/10.1016\/j.lfs.2020.117414","journal-title":"Life Sci"},{"key":"11851_CR90","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/14656566.2020.1729123","volume":"21","author":"KS Johansson","year":"2020","unstructured":"Johansson KS, Br\u00f8nden A, Knop FK, Christensen MB (2020) Clinical pharmacology of imeglimin for the treatment of type 2 diabetes. Expert Opin Pharmacother 21:871\u2013882. https:\/\/doi.org\/10.1080\/14656566.2020.1729123","journal-title":"Expert Opin Pharmacother"},{"key":"11851_CR91","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s13300-025-01693-z","volume":"16","author":"S Shaikh","year":"2025","unstructured":"Shaikh S, Sharma SK, Phatak S, Asirvatham A, Bhattacharyya S, Dhandhania VK et al (2025) A Multicenter, Retrospective Study to Evaluate the Effectiveness and Safety of Imeglimin in Patients with Type 2 Diabetes Mellitus in a Real-World Clinical Setting (INDI-TIMES Study). Diabetes Ther 16:645\u2013661. https:\/\/doi.org\/10.1007\/s13300-025-01693-z","journal-title":"Diabetes Ther"},{"key":"11851_CR92","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/jdi.70092","volume":"16","author":"A Kato","year":"2025","unstructured":"Kato A, Nihei W, Yako H, Tatsumi Y, Himeno T, Kondo M et al (2025) Imeglimin improves hyperglycemia and hypoglycemia-induced cell death and mitochondrial dysfunction in immortalized adult mouse Schwann IMS32 cells. J Diabetes Investig 16:1586\u20131596. https:\/\/doi.org\/10.1111\/jdi.70092","journal-title":"J Diabetes Investig"},{"key":"11851_CR93","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jshs.2020.01.001","volume":"9","author":"LL Ji","year":"2020","unstructured":"Ji LL, Yeo D, Kang C, Zhang T (2020) The role of mitochondria in redox signaling of muscle homeostasis. J Sport Health Sci 9:386\u2013393. https:\/\/doi.org\/10.1016\/j.jshs.2020.01.001","journal-title":"J Sport Health Sci"},{"key":"11851_CR94","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3390\/medicina59071320","volume":"59","author":"HA Al-Rawaf","year":"2023","unstructured":"Al-Rawaf HA, Gabr SA, Iqbal A, Alghadir AH (2023) High-Intensity Interval Training Improves Glycemic Control, Cellular Apoptosis, and Oxidative Stress of Type 2 Diabetic Patients. Med (Mex) 59:1320. https:\/\/doi.org\/10.3390\/medicina59071320","journal-title":"Med (Mex)"},{"key":"11851_CR95","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-021-00831-w","volume":"7","author":"H Zhu","year":"2022","unstructured":"Zhu H, Bi D, Zhang Y, Kong C, Du J, Wu X et al (2022) Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Signal Transduct Target Ther 7:11. https:\/\/doi.org\/10.1038\/s41392-021-00831-w","journal-title":"Signal Transduct Target Ther"},{"key":"11851_CR96","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng Y et al (2024) Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther 9:124. https:\/\/doi.org\/10.1038\/s41392-024-01839-8","journal-title":"Signal Transduct Target Ther"},{"key":"11851_CR97","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/dom.12158","volume":"15","author":"M Lundh","year":"2013","unstructured":"Lundh M, Scully SS, Mandrup-Poulsen T, Wagner BK (2013) Small\u2010molecule inhibition of inflammatory \u03b2 \u2010cell death. Diabetes Obes Metab 15:176\u2013184. https:\/\/doi.org\/10.1111\/dom.12158","journal-title":"Diabetes Obes Metab"},{"key":"11851_CR98","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3892\/ijmm.2024.5436","volume":"54","author":"L Xiong","year":"2024","unstructured":"Xiong L, Hu H, Zhu F, Shi H, Fan X, Pan S et al (2024) New insight for SS\u201331 in treating diabetic cardiomyopathy: Activation of mitoGPX4 and alleviation of mitochondria\u2013dependent ferroptosis. Int J Mol Med 54:112. https:\/\/doi.org\/10.3892\/ijmm.2024.5436","journal-title":"Int J Mol Med"},{"key":"11851_CR99","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s40001-025-02368-y","volume":"30","author":"Z Guo","year":"2025","unstructured":"Guo Z, Huang L, Jiang Z, Bai X, Wang Z, Huang H (2025) Effects of different hypoglycaemic drugs on beta-cell function in type 2 diabetes mellitus: a systematic review and network meta-analysis. Eur J Med Res 30:121. https:\/\/doi.org\/10.1186\/s40001-025-02368-y","journal-title":"Eur J Med Res"},{"key":"11851_CR100","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3233\/JND-210715","volume":"8","author":"MY Tiet","year":"2021","unstructured":"Tiet MY, Lin Z, Gao F, Jennings MJ, Horvath R (2021) Targeted Therapies for Leigh Syndrome: Systematic Review and Steps Towards a \u2018Treatabolome\u2019. J Neuromuscul Dis 8:885\u2013897. https:\/\/doi.org\/10.3233\/JND-210715","journal-title":"J Neuromuscul Dis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11851-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11851-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11851-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:52:15Z","timestamp":1777099935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11851-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11851"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11851-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest or competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable (this article is a review and does not involve human or animal studies).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Registration and Clinical Trial Number"}},{"value":"The author consents to the publication of this manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that OpenAI ChatGPT (GPT-5 model, 2025, OpenAI, San Francisco, CA, USA) was used solely to assist in language editing, grammar correction, and text refinement of the manuscript. The tool was not used for data generation, interpretation, or content creation related to scientific conclusions. All intellectual and conceptual contributions, interpretations, and final revisions were performed by the authors.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of Artificial Intelligence Tools"}}],"article-number":"662"}}